Breitbach S, Sterzing B, Magallanes C, Tug S, Simon P. Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise. J Appl Physiol 117: 119-130, 2014. First published May 29, 2014 doi:10.1152/japplphysiol.00002.2014.-To investigate the kinetics of cell-free DNA (cfDNA) due to exercise, we established a direct real-time PCR for the quantification of cfDNA from unpurified capillary plasma by amplification of a 90-and a 222-bp multilocus L1PA2 sequence. Twenty-six male athletes performed an incremental treadmill test. For cfDNA measurement, capillary samples were collected serially from the fingertip preexercise, during, and several times postexercise. Venous blood was drawn before and immediately after exercise to compare capillary and venous cfDNA values. To elucidate the strongest association of cfDNA accumulations with either cardiorespiratory or metabolic function during exercise, capillary cfDNA values were correlated with standard measures like heart rate, oxygen consumption, or lactate concentrations. The venous cfDNA concentrations were significantly higher compared with the capillary plasma, but in both fractions cfDNA increased 9.8-fold and the values correlated significantly (r ϭ 0.796). During incremental treadmill running, the capillary cfDNA concentrations increased nearly parallel to the lactate values. The values correlated best with heart rate and energy expenditure, followed by oxygen consumption, Borg values, and lactate levels (0.710 Յ r Ն 0.808). With this article, we present a sensitive procedure for the direct quantification of cfDNA in unpurified capillary plasma instead of purified venous plasma. Further studies should investigate the differences between capillary and venous cfDNA that might mirror different physiological mechanisms. Enhanced cardiorespiratory function during exercise might lead to the accumulation of cfDNA via the release of stress hormones that already increase at intensities below the anaerobic threshold. Furthermore, cfDNA might be released by neutrophil extracellular traps.
THE PHENOMENON OF CIRCULATING cell-free DNA (cfDNA) is gaining interest in various biomedical disciplines, including the field of exercise physiology. Acute effects of exercise on cfDNA concentrations have been investigated due to resistance training (4), half-marathon (5) and ultra-marathon running (3), continuous treadmill running (24) , interval running and incremental treadmill tests (7) , and incremental rowing exercise (74) . The studies demonstrated consistently that cfDNA levels had increased until the cessation of exercise, with a rapid return to baseline levels during 1-2 h of recovery [except for the setting of the ultra-marathon (3)].
The exercise-induced increases of cfDNA concentrations have been supposed to trigger or to be related to adaptations of the immune function (2, 12, 68) . However, the entire mechanism leading to elevated cfDNA levels has not been elucidated until now. In many clinical issues, it has been assumed that the cfDNA fragments result from necrosis and apoptosis of blood and tissue cells (44, 45) . Since typical necrosis or apoptosis has been shown to release cfDNA into the circulation after hours due to the cell death-inducing stimulus (33, 45, 48, 56) , it is unlikely that these mechanisms account for increases of cfDNA concentrations in short exercise settings (12) . More spontaneously occurring mechanisms were supposed to induce the accumulations of cfDNA during exercise, like an active release of extracellular or intracellular DNA (2, 50, 68, 70) , or extracellular trap formation (7) . Due to the major gaps in understanding the entire phenomenon, the relevance of cfDNA in the arena of sports physiology remains highly underinvestigated. Baseline cfDNA concentrations in resting conditions, relative or absolute elevations due to exercise, or the degradation rate postexercise might be associated with the individual performance level, operate as markers of metabolic or oxidative stress (7), or mirror a condition of overtraining (23) . To investigate the associations of cfDNA accumulations with various aspects of exercise, serial sampling during exercise would be required, like it has been shown by Beiter et al. (7) . They demonstrated a rapid increase of cfDNA concentrations in an incremental treadmill test. Essential cfDNA accumulations occurred after an average of 10 min of running with an approximate intensity of 70% of the velocity at the individual anaerobic threshold (V IAT ). A strong increment of cfDNA concentrations was shown after 15 min of exercise within a time interval of only 3 min.
However, compared with the established procedures to measure lactate or oxygen consumption (V O 2 ) during exercise (22, 35) , the current procedures for the assessment of cfDNA in the exercising subject appear suboptimal. The analyses comprise blood sampling from the antecubital vein with subsequent DNA purification from plasma or serum. On the one hand, the puncture of the vein during exercise is not practicable and might induce high losses of blood, circulatory incidents, and long interruptions of the exercise protocol. On the other hand, the purification of cfDNA is accompanied by several technical disadvantages, like the requirement of large amounts of blood samples (54) , time-consuming laboratory work, risk of contamination, PCR inhibiting ingredients (42) , and loss of DNA due to the small fragment sizes (15, 19, 27, 28, 40, 41) .
Our research group has recently demonstrated a direct quantitative real-time PCR (qPCR) amplifying an abundant L1PA2 sequence for the quantification of unpurified cfDNA in plasma (13) . The comparison of cfDNA concentrations determined by either amplification of a single locus MSTN sequence or the multilocus L1PA2 sequence revealed no significant quantitative differences. The direct qPCR yielded, on average, 2.8-fold higher cfDNA concentrations in untreated plasma compared with the eluate of conventional silica-or phenol-chloroform isoamyl-based methods and thus overcomes the losses of DNA during purification. Another advantage of this new procedure is the requirement of only minimal amounts of plasma template for cfDNA quantification. It, therefore, allows sampling of droplet volumes of blood from capillary sites. Based on this state of research, the aim of the present study was to establish a procedure that allowed sampling of minimal capillary blood volumes in short time intervals during exercise and subsequent processing for quantification of cfDNA using the new L1PA2 qPCR.
To show the relevance of this procedure in the context of exercise physiology and to take up the current status of research in this field, the present study included cfDNA measurement in capillary and venous plasma before, during, and after incremental treadmill running. Significant correlations were expected between the accumulations of cfDNA and cardiorespiratory or metabolic function during incremental exercise (7, 51) . Until today, the association of cfDNA accumulations with physiological standard measures, like V O 2 , energy expenditure, or lactate concentrations, has only been discussed theoretically (12) . To establish the applicability of cfDNA quantification from capillary plasma, the comparison of capillary and venous cfDNA concentrations was considered crucial. For other metabolites like lactate, glucose, or insulin, quantitative differences have been shown between capillary and venous blood, while the concentrations measured at both sites correlated significantly (29, 36, 49) . Therefore, the following hypotheses were of central interest in the present study: 1) cfDNA values measured in capillary and venous plasma correlate significantly; 2) cfDNA concentrations increase progressively during incremental treadmill running in capillary plasma; and 3) accumulations of capillary cfDNA correlate significantly with other physiological measures during incremental exercise.
METHODS
Ethical approval. All experimental procedures were approved by the Human Ethics Committee of Rhineland-Palatine and conformed to the standards of the Declaration of Helsinki of the World Medical Association. All subjects were informed orally and in writing about the procedures and the aim of the study and gave written consent to participate.
Subjects. Twenty-six male athletes [13 handball players and 13 triathletes; mean (SD) age 24.7 (3.1) yr, height 184.2 (7.2) cm, weight 82.7 (10.8) kg] participated in the study (Table 1 ). The recruitment of the participants was based on the aim of testing athletes from either continuous or intermittent sports to find possible differences in the accumulations or subsequent degradation of cfDNA between these types of athletes. To exclude performance effects on the cfDNA values, the handball players and triathletes were matched for the amount of training hours per week. Therefore, the handball players were part of the German regional leagues exhibiting on average 6.8 (3.1) training hours per week, while the triathletes were recruited from the recreational sector with 8.8 (3.3) training hours per week.
Exercise protocol. The participants performed an incremental treadmill test until volitional exhaustion with a minimum of five completed steps to reliably determine the individual anaerobic threshold. The exercise protocol started at a velocity of 6 km/h and was increased for 2 km/h every 3 min until the subjects terminated running. The treadmill stopped automatically for 30 s before each speed increment to collect capillary blood samples from the fingertip for cfDNA measurement, and from the hyperemized earlobe for the determination of lactate concentrations. Each exercise test included continuous recording of spiroergometric (respiratory) data and heart rate. Borg scale values were inquired at the end of each 3-min interval. After exercise termination, the participants walked for 5 min to commence recovery. Until 90 min postexercise, the participants were recommended to sit down or walk slowly. The participants were asked to pause from regular exercise during the last 24 h before the test.
Blood sampling and processing. In the incremental treadmill test, 20 l of capillary blood were collected with a dipotassium-EDTA covered Microvette CB 300 (Sarstedt, Nürnbrecht, Germany) from the fingertip before exercise, at the end of every exercise step, at the point in time of volitional exhaustion, and after 3, 5, 20, and 90 min of recovery. The respective collection site was cleaned thoroughly with a swab containing a disinfectant solution before puncture. After the stitch, the first drop of blood was discarded. To avoid sweat accumulations in the blood samples, the collection site was cleaned again with a disinfectant swab, and the sample was collected immediately thereafter. Before and immediately postexercise, 17.5 ml of EDTA-coagulated blood were taken from the antecubital vein. Two and one-half milliliters of the venous blood were sent to an external contract laboratory for the analyses of complete blood counts. The remaining blood samples were centrifuged immediately after exercise termination or directly after collection at 4°C, 1,600 g for 10 min (Centrifuge 5424 R, Eppendorf, Hamburg, Germany). The supernatants of both sampling methods were high-speed centrifuged at 4°C, 16,000 g for 5 min to remove cell debris from the plasma (18) . The final plasma samples were stored at Ϫ20°C for up to 4 mo until qPCR measurement. Blood samples for lactate measurement were taken from the earlobe with heparinized capillary tubes at each point in time of capillary blood sampling for cfDNA analyses and were subsequently measured with the automatic lactate analyzer Biosen 5130 (EKF Diagnostics, Magdeburg, Germany).
qPCR reaction and conditions. cfDNA concentrations were quantified by implementing unpurified plasma in a direct qPCR using a Taq polymerase that is capable of extending 1 kb per 10 s (Velocity Polymerase, Bioline, Luckenwalde, Germany). All templates were measured in triplicates for the determination of test and software variations.
The plasma was diluted in a ratio of 1:40 in H2O. Diluted plasma (2.2 l) was added as template to 14.3 l master mix containing 1 U/l Tego buffer (Bioline), 0.05 U/l velocity polymerase (Bioline), 0.17ϫ SYBR Green (Sigma-Aldrich, Taufkirchen, Germany), 0.001 M FITC (Sigma-Aldrich,), 0.6 mM MgCl2, and 0.34 M each primer. The total volume of reaction mixture per template was 16.5 l, adequate for three measurements of 5 l plus pipetting loss. All reactions included a triplicate of nontemplate controls. Reactions were carried out in 384-well PCR plates (0.2-ml tube plate, white, Peqlab, Erlangen, Germany) using the CFX Touch Real Time PCR Detection System (Biorad, Munich, Germany) for qPCR measurement. The amplification consisted of an initial denaturation at 98°C for 2 min, followed by 35 cycles of melting at 94°C for 10 s, annealing at 64°C for 40 s, and extension at 75°C for 10 s. Subsequent qPCR reactions were adjusted to interplate-calibration templates that were measured on several plates containing an L1PA2 standard dilution series.
Primer design. The primer sets for the direct qPCR were designed for the amplification of a 90-bp and a 222-bp multilocus L1PA2 consensus sequence of the class L1 of the human long interspersed elements. L1PA2 sequence information was attained from the University of California Santa Cruz (UCSC) Genome Browser (http:// genome.ucsc.edu) for primer design and matches with the human genome and consensus DNA design for standard curves. The program Primer3 (http://frodo.wi.mit.edu/primer3/; Ref. 59 ) was used to design two primer sets for a 90-bp L1PA2 amplicon (L1PA2 90) with 3,345 matches and a 222-bp L1PA2 amplicon (L1PA2 222) with 3,134 matches in the human genome. For both amplicon lengths, the forward primer sequences were 5=-TGC CGC AAT AAA CAT ACG TG-3=, while the reverse primer sequence for L1PA2 90 was 5=-GAC CCA GCC ATC CCA TTA C-3= and for L1PA2222 5=-AAC AAC AGG TGC TGG AGA GG-3=. The DNA integrity was calculated as the quotient of cfDNA concentrations determined by amplification of the longer L1PA2222 and the shorter L1PA290 fragments.
L1PA2 custom DNA standard sequence. A 401-bp L1PA2 custom DNA sequence was designed using Primer3 and synthesized in a pEx-A plasmid by Eurofins MWG Operon (Ebersberg, Germany). The L1PA2 sequence was separated from the plasmids, manifolded in a PCR (HotStar HiFidelity PCR Kit, Qiagen, Hilden, Germany), purified with the Fermentas GeneJET PCR Purification Kit (Thermo Fisher Scientific, Dreieich, Germany), and diluted in 60 l of TE (Tris-EDTA) buffer [for further information see Breitbach et al. (13) ]. The concentration of L1PA2 fragments in the stock solution was determined by fluoro-spectrometric measurement (NanoDrop 3300, Thermo Fisher Scientific). Using the program Finnzymes (http:// www.thermoscientificbio.com/webtools/copynumber/) the initial copy number of the calibrator dilution in the standard series was calculated.
Standard curves and limit of quantification. For an absolute quantification of cfDNA fragments, a standard curve of serial dilutions of defined L1PA2 copy numbers in TE buffer was inserted in the qPCR, ranging from 10 6 to 78 copies/l, with one copy being a doublestranded DNA fragment in a haploid cell. To meet the conditions of plasma template measurement, the reaction for the measurement of the standard curve was spiked with murine plasma. It has been shown previously that the ingredients of plasma in the reaction mixture, like proteins, minerals, and EDTA, did not have an inhibitory effect on the amplification (13) . For the detection of the lowest limit of quantification (LOQ), representing the lowest concentration that can be quantified with a determined level of precision, the standards were measured as septets with 1 l of the L1PA2 standard dilutions per well. The LOQ was defined as the lowest copy number that revealed not more than 20% standard deviation in a septet of a standard dilution (7, 34) . The limit of detection (LOD) as the lowest copy number that can be detected and reliably distinguished from zero or the level of background noise was estimated from 12 independent measures of blanks, as proposed by González and Herrador (34) . In each dilution, the measured threshold cycle (Ct) value was plotted against the logarithm of the calibrator copy number (66) . For the validation of cfDNA measurement, the qPCR efficiency was determined as proposed by Mygind et al. (57) .
Statistical analysis. The qPCR data were captured with the CFX Manager Software version 3.0 (Biorad) and Microsoft Excel 2007 (Microsoft, Redmond, WA). Statistical analysis was performed using SPSS Statistics version 19 (IBM, Chicago, IL). For the establishment of the laboratory method, statistics included the determination of PCR efficiency as proposed by Mygind et al. (57) to exclude inhibitory effects. The data collected during the incremental exercise test were filtered for different points in time of blood sampling and tested for normal distribution. For normally distributed data, correlations were analyzed for the Pearson's correlation coefficient, including the fold increases of cfDNA and lactate concentrations from preexercise to postexercise, and maximum metabolic and respiratory values at the end of exercise. If the data did not meet the criteria of normal distribution, a Spearman's rho test was calculated for nonparametric correlations, as done for capillary and venous cfDNA concentrations pre-and postexercise, and capillary cfDNA, lactate, cardiorespiratory, and Borg values obtained during the incremental test. Univariate ANOVA was assessed for the comparison between cfDNA concentrations measured in capillary and venous plasma pre-and postexercise. Multivariate analysis of variance (MANOVA) was performed for comparisons of means of logarithmic data of cfDNA and lactate concentrations and DNA integrity values at different points in time, and for the assessment of possible effects of the groups of handball players or triathletes. Post hoc tests included Bonferroni correction for multiple analyses. Multiple regression analysis was conducted with normally distributed logarithmic data of V O2 and lactate as independent predictors of the dependent variable of capillary cfDNA concentrations during exercise. cfDNA concentrations or cfDNA curves containing concentrations below the LOQ were excluded from statistical analysis.
RESULTS

Linearity and sensitivity of qPCR.
The standard curves of the L1PA2 90 and the L1PA2 222 amplicons had linearity ranging from 10 6 to 78 copies/l and 10 6 to 117 copies/l, respectively. For the L1PA2 90 amplicon, the LOQ was determined at 103 copies/l (Ct 29.46), and the LOD was estimated at 32.6 copies/l (Ct 30.83). The amplification had a PCR efficiency of 96.1%, and linear regression analysis of mean Ct values per septet against log concentrations in the dilution yielded r Ͼ 0.99 (Fig. 1) . The LOQ of the L1PA2 222 amplicon was fixed at 122 copies/l (Ct 28.17). The analysis revealed a LOD at 17.0 copies/l (Ct 30.95), a PCR efficiency of 94.5%, and a regression coefficient of r Ͼ 0.99 ( Fig. 1) . A conversion of standard copy numbers at the LOQ to cfDNA concentrations yielded 2.0 ng/ml plasma for L1PA2 90 and 2.2 ng/ml plasma for L1PA2 222 as limits for sensitive measurement.
Incremental treadmill test. The incremental treadmill tests were terminated on average after 5.98 (0.63) steps at 16.0 (1.2) km/h (Table 2) , revealing an average exercise duration of 17.9 (1.9) min. The participants reached a respiratory exchange ratio of, on average, 1.08 (0.05). Further data captured during the whole test procedure were statistically analyzed for 1) preexercise levels compared with postexercise levels in the capillary and venous fractions; 2) the course of the exercise test with serial sampling of capillary blood, taking into account preexercise levels and values of each completed 3-min running interval; and 3) the recovery phase until 90 min after the termination of the incremental test. Since no differences were found between the groups of handball players and triathletes in terms of absolute cfDNA or DNA integrity values at baseline conditions, at any point in time during and after exercise or in the kinetics of cfDNA during and after exercise, the following results were presented for the entire group of participating athletes.
The cfDNA L1PA2 90 concentrations in capillary plasma increased from initially 8.7 (5.8) ng/ml to 68.3 (39.6) ng/ml immediately postexercise ( Fig. 2A) . In venous plasma, the L1PA2 90 concentrations were significantly higher than in the capillary fraction at both points in time [preexercise, 17.6 (11.1) ng/ml; postexercise, 153.2 (102.1) ng/ml; P Ͻ 0.001; . Note that analysis of the DNA integrity was calculated for n ϭ 18, since eight athletes showed capillary L1PA2 222 values below the LOQ. No significant difference existed between the mean DNA integrity values preexercise and postexercise in the respective plasma fraction. However, in the venous fraction, three participants showed exceptionally high baseline DNA integrity values between 0.7 and 1.0 that decreased postexercise to levels in the range of the total values (Fig. 2D ). An exclusion of these three participants revealed a significantly higher venous DNA integrity postexercise compared with baseline conditions. The mean DNA integrity differed significantly between capillary and venous plasma postexercise. Table 3 presents the blood counts determined by the external contract laboratory. Postexercise, the fractions of leukocytes, erythrocytes, hemoglobin, hematocrit, platelets, and lymphocytes increased significantly compared with the resting condition, while the number of neutrophils decreased. A significant difference between the groups of handball players and triathletes was only found in the numbers of platelets preexercise. There was no significant correlation between the fold differences of cfDNA concentrations and blood counts from preexercise to postexercise.
The capillary cfDNA concentrations increased continuously and nearly parallel to the lactate values from the onset of exercise (Fig. 3, A and B) . Post hoc analysis revealed a significant rise of cfDNA concentrations at the end of the 10 km/h stage, corresponding to 62.9 (4.8) %V max . The lactate concentrations increased from 0.7 (0.3) mmol/l preexercise to 9.8 (1.7) mmol/l postexercise, with significant increments immediately after the onset of running the 6 km/h stage [37.8 (2.9) %V max ] and after the 12 km/h stage [75.5 (5.8) %V max ]. Figure 3C presents the DNA integrity over the course of running. Post hoc analysis yielded a significantly higher mean DNA integrity value after the onset of exercise compared with baseline conditions. During the following stages, a slight but not significant depression of the median DNA integrity value was observed. Since eight athletes yielded L1PA2 222 concentrations below the LOQ before or during the first steps of exercise, the mean concentrations, correlation coefficients with L1PA2 90 , DNA integrity values, and MANOVA were determined for only 18 subjects (n ϭ 18).
The concentrations of capillary L1PA2 90 correlated well with metabolic and cardiorespiratory measures and values of perceived exertion over the course of incremental running. Correlation analyses of L1PA2 90 concentrations yielded r ϭ 0.710 with lactate concentrations, r ϭ 0.808 with heart rate, r ϭ 0.801 with V O 2 , r ϭ 0.808 with energy expenditure, and r ϭ 0.758 with Borg values (P Ͻ 0.01; Table 4 ). The concentrations of the longer L1PA2 222 fragments revealed 4.7 (2.6) ng/ml (minimum 2.4 ng/ml; maximum 11.6 ng/ml) at baseline conditions and showed similar kinetics compared with the short L1PA2 90 during exercise. Spearman's rho correlation for both amplicon lengths revealed a coefficient of r ϭ 0.922 (Table 4) . No significant differences were found between the two At both points in time, the cfDNA L1PA290 concentrations were significantly higher in venous plasma. C and D: the DNA integrity showed individual alterations due to exercise. C: in capillary plasma, the mean integrity did not change significantly from pre-exercise to postexercise. D: in the venous fraction, the mean DNA integrity indicated higher DNA integrity values postexercise compared with preexercise, except for 4 subjects. Postexercise, the mean DNA integrity differed significantly between capillary and venous plasma. Note that statistical analysis and presentation of the DNA integrity values were performed for n ϭ 18, since 8 athletes yielded L1PA2222 concentrations below the limit of quantification (LOQ) before exercise. groups of handball players and triathletes in these parameters over the course of exercise. Multiple-regression analysis indicated a significant effect of lactate (␤ ϭ 0.226; P ϭ 0.006) and V O 2 (␤ ϭ 0.565; P Յ 0.001) on cfDNA, accounting for 55.5% of capillary cfDNA concentrations (r corr 2 ϭ 0.549). After termination of the incremental exercise test, further capillary samples were collected at 3, 5, 20, and 90 min of recovery to monitor the degradation of cfDNA and lactate. The athletes showed an individual development in cfDNA concentrations during the first 20 min. In most of the participants, cfDNA concentrations peaked 3 min postexercise and decreased continuously thereafter. In other athletes, cfDNA concentrations increased until 20 min postexercise (Fig. 4A) . MANOVA revealed a significant decrease of cfDNA concentrations from 20 min to 90 min postexercise. However, the cfDNA values after 90 min of recovery were still significantly elevated compared with preexercise levels [L1PA2 90 , preexercise, 8.7 (5.8) ng/ml; postexercise 90 min, 13.4 (6.8) ng/ml].
The degradation of lactate yielded a more homogeneous pattern with a strong decline from 5 min postexercise in all participants (Fig. 4B) . Until 90 min of recovery, the lactate concentrations still remained significantly elevated [1.3 (1.0) mmol/l]. During recovery, the L1PA2 90 and lactate concentrations correlated significantly but less well than during the incremental exercise (r ϭ 0.677).
Analyses of the DNA integrity indexes during recovery revealed a significant difference between the 20th min and the The analyses on DNA integrity values were based on 24 subjects, because 2 subjects showed L1PA2 222 concentrations below the LOQ during recovery.
DISCUSSION
With the direct L1PA2 qPCR applied in this project, we recommend fast and sensitive quantification of cfDNA from diverse fluids without preceding DNA purification, overcoming the prevailing short-comings of DNA extraction methods (15, 27, 40, 42) . In previous trials, we showed that the quantification of cfDNA from unpurified plasma yielded significantly higher cfDNA concentrations compared with the eluate of different DNA extraction procedures (13) . This direct qPCR is based on the application of a special Taq polymerase for difficult templates with fast extension of up to 1 kb per 10 s (Velocity Polymerase, Bioline) and on the amplification of two lengths of an abundant L1PA2 sequence. Umetani et al. (71) (72) (73) already introduced a qPCR approach for the direct quantification of cfDNA from "pre-procedured" but unpurified plasma or serum by the amplification of abundant ALU repeats. Until today, only the ALU primers, but not the pre- (21, 26, 52) , which might be due to several disadvantages of this approach (13) . However, the amplification of abundant sequences was supposed to increase the sensitivity of cfDNA measurements (40, 67) . L1PA2 repeats occur well distributed and more than 3,000-fold in the human genome (13) . In opposition to a single-copy gene, the abundant binding sites for primers enable the quantification of cfDNA in the highly diluted plasma templates. The procedure is sensitive enough to distinguish templates of low cfDNA content from sample blanks. Nevertheless, the LOQ of the L1PA2 qPCR was determined in a range, where physiological cfDNA baseline levels may still occur, and may limit the assessment of changes from baseline levels in healthy humans. In the present study, 6% of the concentrations of L1PA2 222 were below the LOQ in the capillary plasma and were excluded from the statistical analysis. Nevertheless, these values were still above the estimated LOD, as proposed by González and Herrador (34) , which can be expected one-third to one-tenth of the LOQ of the L1PA2 qPCR. Analysis of the fragment length of the L1PA2 qPCR product (Fragment Analyzer, Advanced Analytical Technologies, Heidelberg, Germany; data not shown) evidenced that the length of the L1PA2 target sequence occurred identically in humans. More abundant sequences like the ALUs, however, might exhibit interindividual differences in their specific sequences (6), yielding inhomogeneous PCR product lengths with biased fluorescents signals in the qPCR measurement. A further advantage of the presented target sequence is that the human L1PA2 is not present in the genome of mice. In vivo mouse models comprising the measurement of human cfDNA concentrations in the blood or tissue of mice might, therefore, be conducted by amplification of L1PA2.
The direct L1PA2 qPCR requires only 2 l of initial template volume for sensitive proceeding. Therefore, the quantification of cfDNA concentrations is no longer restricted to large volumes of venous blood and might be used for analysis of capillary fractions or mouse models. We are not aware of any other research group having demonstrated the measurement of cfDNA from capillary plasma. Since Beiter et al. (7) showed venous cfDNA concentrations to describe a lactate-like kinetics during incremental treadmill running, this setting appeared practicable to investigate the property of determining cfDNA concentrations from the capillary fraction. For this purpose, approaches for capillary sampling were performed both from the earlobe and from the fingertips. However, the expected curve of cfDNA concentrations shown by Beiter et al. (7) could only be reproduced in capillary plasma collected from the fingertips (data of cfDNA concentrations measured in plasma from the earlobe were not shown), which might be due to the better blood flow after puncture compared with the earlobe. Firm pressure to increase the blood flow during sampling seemed to falsify the exercise-induced changes of cfDNA concentrations.
The comparison of cfDNA concentrations measured from capillary and venous plasma revealed on average 50% lower cfDNA concentrations in the capillary fraction. The phenomenon of differing compositions and conditions between capillary and venous blood have been reported for several aspects. Schalk et al. (64) , for example, found higher proportions of hemoglobin, hematocrit, leucocytes, neutrophils, and erythrocytes, but less thrombocytes in capillary blood compared with venous blood. Furthermore, lactate concentrations were shown Direct Measurement of Cell-Free DNA from Capillary Plasma • Breitbach S et al. to be 8% lower in venous than in capillary blood (29) , which might be the result of lactate uptake and utilization by muscles and organs (20) . Cortisol concentrations yielded up to 3.5% higher levels in venous blood than in the capillary fraction (31) . However, none of the cited articles reported differences of up to 50% between both blood fractions. The physiological mechanisms causing these differences in cfDNA concentrations can only be speculated at the current state of research. Due to Schalk et al. (64) , the capillary blood was described to stem mainly from arterioles instead of capillaries or small veins, where the capillary blood withdrawal induced a laminar blood flow with a faster central stream comprising higher counts of erythrocytes and leukocytes, while thrombocytes and plasma were described to be mainly found at the margin of the vessels. Yen et al. (75) delineated that, at a capillary bifurcation, shear stress and pressure forced erythrocytes to enter the faster channel, leading to an uneven distribution of red cells and possibly other blood components in the capillaries. The venous cytoplasm has also been shown to be thicker than the capillary cytoplasm, enabling veins but not capillaries to occupy up to one-fifth of their endothelial cytoplasm with membrane-bound vesicles and vacuoles (1), which might be associated with the phenomenon of cfDNA. Furthermore, endothelial cells at the interior surface of blood vessels are located in straight segments of the vessels, but not at bifurcations, which exist more frequently in the capillaries (1). Following Morozkin et al. (55) , endothelial cells even generate and absorb cfDNA. The described differences concerning endothelial structure and function or conditions of shear stress, O 2 , and V O 2 ratios or blood pressure between capillary and venous vessels might play a role in the accumulation of cfDNA and cause the observed differences in the recent study.
Nevertheless, cfDNA concentrations measured from capillary and venous plasma correlated highly with r ϭ 0.796, confirming our first hypothesis. Similar correlation coefficients were found for the cell counts in both blood fractions (0.7 Ͻ r Ͼ 0.9; Ref. 64) . Further investigations should be conducted to explain the differences between capillary and venous cfDNA levels and to elucidate whether the respective fractions are linked to different physiological mechanisms.
Compared with baseline levels, the cfDNA L1PA2 90 concentrations in capillary and venous plasma increased 9.8-fold immediately postexercise, which is in line with the observations of Beiter et al. (Ref. 7; 9.9-fold increase of venous cfDNA levels). To a small extent, the changes in cfDNA concentrations might result from the reduction of plasma volume postexercise, which has been shown to decrease by ϳ5-10% after incremental treadmill running (30) and may be underlined by the changes in venous blood cell counts in this present study. The fold increases of cfDNA, absolute cfDNA concentrations immediately postexercise, or the individual maximum cfDNA concentration did not correlate either with the peak running velocity, the V IAT , or training hours per week. These results strengthen the assumption that the kinetics of cfDNA, unlike lactate levels (43) , are not related to the individual performance level or modifiable by training. The findings, furthermore, did not indicate any association of the release or removal of cfDNA with the metabolic profile of an athlete who has adapted to either mainly intermittent or endurance training (handball vs. triathlon). Recent exercise studies on cfDNA accumulations due to running events only comprised testing merely endurance athletes (3, 5, 7), or did not specify the group of participants (24) . In the present study, no significant differences were found between handball players and triathletes with regard to absolute cfDNA or DNA integrity values at baseline conditions, at any point in time during and after exercise or in the kinetics of cfDNA during and after exercise. However, the incremental treadmill test might not have been the optimal setting to answer this question, since it did not meet the typical exercise profile of handball playing or triathlon. To ensure this finding, another approach should aim to compare cfDNA accumulations due to intermittent and continuous exercise settings in both groups.
The lactate-like curve of capillary cfDNA concentrations in the incremental treadmill test confirmed with the kinetics of venous cfDNA concentrations in Beiter et al. (7), showing a continuous increment during exercise and a rapid decrease during recovery (hypothesis 2). Beiter et al. (7) assumed a strong association between the accumulations of lactate and cfDNA levels, since increasing lactate induced the production of reactive oxygen species (ROS), oxidative stress, cellular proliferation, or tissue damage in various conditions exhibiting elevated cfDNA levels. However, the associations between lactate and cfDNA and the mechanisms underlying this hypothesis have yet to be elucidated. On the one hand, Hashimoto et al. (38) suggested a ROS-producing effect of lactate, since incubation of L6 cells with exogenous lactate increased the intracellular hydrogen peroxide (H 2 O 2 ) production. On the other hand, lactate production during exercise is always associated with acidosis, indicating that rather lactic acid than the lactate ion exhibits the prooxidant effect due to increasing H ϩ or dissociation of protein-bound iron (37, 60) . Meanwhile, substantial evidence exists concerning an antioxidant effect of lactate and pyruvate by scavenging of ROS (37, 63) . In the recent study, heart rate, energy expenditure, and cardiorespiratory parameters correlated even better with cfDNA concentrations than lactate (hypothesis 3). A significant elevation of cfDNA occurred at the end of the 10 km/h running interval [corresponding to 62.9 (4.8) %V max ; 82.7 (7.4) %V IAT ], while the lactate concentrations increased significantly later after the 12 km/h stage [75.5 (5.8) %V max ; 99.2 (8.9) %V IAT ]. Measurements of cfDNA and lactate kinetics in four subjects performing continuous treadmill running over 30 min at the V IAT furthermore indicated that cfDNA accumulated constantly, although lactate concentrations approximated a steady state (data not shown). Therefore, the release of cfDNA might rather not merely be triggered by increasing lactate concentrations, and the accumulations of cfDNA and lactate might not directly underlie one common mechanism. However, multiple regression analysis revealed a significant effect of lactate on cfDNA concentrations. Furthermore, the V O 2 exhibited an effect on cfDNA, which was independent from the effect of lactate. Since no other variables were included in the regression model, and even the causality in the relationship of the lactate-topyruvate ratio and the responses of the V O 2 remain unclear (22, 39) , a further interpretation of these results is difficult.
The significant rise of cfDNA concentrations at the end of the 10 km/h stage corresponded to an exercise intensity, when most of the athletes had passed or at least approximated their aerobic threshold. A first increase in serum stress hormones epinephrine and norepinephrine occurs before reaching the lactate or anaerobic Direct Measurement of Cell-Free DNA from Capillary Plasma • Breitbach S et al. threshold as earliest indicator of a physical stress reaction in incremental treadmill exercise (22) . Since elevated cfDNA levels have been shown to occur unspecifically in various pathological conditions, their accumulations might be triggered by any kind of stress reaction inside the organism. Acute anaerobic exercise was described to increase glucocorticoid production, with lactate playing a role in the stimulation of cortisol that increased until 15 min postexercise (47, 58) . Zhang et al. (77) showed 4.1-to 7.6-fold increases of plasma epinephrine, norepinephrine, and dopamine due to incremental treadmill exercise that returned to baseline within 1 h of recovery. Catecholamines stimulate ␤-adrenoceptors that induce detachment of natural killer cells from vascular endothelial cells into the circulation as part of the immune reaction due to exercise (9, 46, 65, 77) . Significant increases of leukocyte and lymphocyte counts, including natural killer cells, were shown by Zhang et al. (77) after incremental treadmill running and were in line with the results of the present study. However, although leukocyte counts increased, the number of neutrophils significantly decreased. To prove whether increasing stress hormones cause the release of cfDNA, a future experiment should investigate changes of cfDNA concentrations after the infusion of catecholamines under resting conditions. Investigations of further mechanisms possibly inducing accumulations of cfDNA in healthy persons should be uncoupled from physical activity to exclude the impact of shear stress caused by muscle contraction. Beiter et al. (8) recently evidenced the formation of neutrophil extracellular traps (NETs) due to exercise. NETs contribute to the innate immune system and may respond to exercise-induced ROS by releasing a network of nuclear DNA, histones, and proteins (14) . Although no significant correlation between the exercise-induced fold differences of cfDNA concentrations and neutrophil counts existed in this study, recent research indicated that the release of NETs does not necessarily cause cell death in the NETosing neutrophils (76) . The decline of neutrophils detected in the recent study might, therefore, not mirror the total amount of cells releasing (cf)DNA, if a certain count of neutrophils remained viable after having ejected its DNA. Another observation of NETosis pointing to parallels with the phenomenon of accumulating cfDNA refers to a significant release of histones and elastase within minutes in response to an intradermal injection of pathogens (76) . In opposition to apoptosis or necrosis, this mechanism may lead to the spontaneous release of DNA that has been observed in the recent study and by Beiter et al. (7, 8) . However, further investigations need to verify if cfDNA stems from fragmented NETs, since Syu et al. (69) recently showed NETs to increase only in sedentary but not in active people due to strenuous exercise.
The participants showed individual kinetics in the clearance of cfDNA in capillary blood postexercise. The cfDNA concentrations peaked immediately, or between 3 and 20 min postexercise, and decreased continuously thereafter. After 90 min of recovery, mean cfDNA concentrations had not returned to preexercise levels. These results were in line with Beiter et al. (7) , who demonstrated maximum cfDNA levels immediately and 5 and 10 min postexercise in the venous plasma of three participants. Thirty minutes postexercise, cfDNA concentrations remained 4.1-fold higher compared with baseline levels. Therefore, participants performing continuous treadmill running at 70 -75% of maximum V O 2 for 45 min with subsequent intensification to 90% of maximum V O 2 until exhaustion yielded cfDNA baseline levels after 1 h of recovery (24) , while cfDNA concentrations after an ultra-marathon still remained elevated after 2 h of recovery (3). The entire mechanism accounting for the clearance of cfDNA from the circulation still remains unclear, and thus an interpretation of interindividual differences or associations of the degradation rate with the exercise mode is hardly possible. However, from delivery studies, Lo et al. (53) estimated the half-life of cfDNA to be 16.3 min, with a range of 4 -30 min. In ϳ50% of the subjects in the present study, the mean half-life rate of ϳ15 min could be verified. The remaining subjects described completely different cfDNA curves with either strong declines between 3 and 5 min postexercise, or a second (smaller) peak after 20 min postexercise. The degradation mechanism has furthermore been supposed to underlie the DNase concentration and activity in the blood (53, 70) or filtration by liver or kidney (10, 32) .
The amplification of two lengths of the L1PA2 sequence allowed the calculation of DNA integrity values for each point in time of sampling, which has not been investigated during or postexercise until now. In previous studies, the DNA integrity in patients suffering from diverse cancers has been shown to be significantly higher compared with healthy controls (61, 62, 73) . Since exhaustive exercise induces processes equal to pathological conditions, like leukocyte inflammation (25) , oxidative stress (17) , and mechanical and metabolic cell damage (11) , it seemed reasonable that DNA integrity values increased postexercise. However, individual analysis revealed different alterations of DNA integrity values in both fractions due to exercise, with some subjects yielding a higher DNA integrity postexercise, while the integrity in other participants decreased. Nevertheless, the venous fractions indicated significantly higher DNA integrity values postexercise in subjects with normal integrity indexes at baseline conditions. During recovery, the capillary DNA integrity decreased with significantly lowest levels 20 min postexercise in nearly all subjects, indicating a faster disappearance of the longer L1PA2 222 fragments compared with the shorter L1PA2 90 fragments. Tamkovich et al. (70) associated accumulations of cfDNA with the availability of DNase in the blood that cleaved the cfDNA fragments into smaller subfractions between two nucleosomes (see also Ref. 16 ). DNase activity has recently been shown to increase in healthy subjects in response to exercise-induced accumulations of cfDNA as a degradation mechanism to recover baseline conditions (74) . A slightly delayed increase in DNase activity compared with the release of cfDNA might explain higher DNA integrity values postexercise and minimum DNA integrity values after 20 min of recovery.
In our previous work, we analyzed the DNA integrity in venous plasma collected before and after a 10-km relay race, where the participants executed ten 1,000-m runs with several minutes of rest during each run (13) . Within this setting, the mean DNA integrity was lower postexercise compared with baseline levels, which might be due to the different accumulation and degradation rates during the single exercise intervals with subsequent long recovery phases.
Since the phenomenon of either pathological and exerciseinduced accumulations of cfDNA in the blood remains widely unexplained, the relevance of cfDNA concerning performance levels and disciplines, the degree of physical exhaustion, or Direct Measurement of Cell-Free DNA from Capillary Plasma • Breitbach S et al. overtraining status still remains unclear. With this article, we provide a method for the direct quantification of cfDNA from unpurified capillary plasma that allows fast, regular, and minimally invasive blood sampling in various settings with subsequent sensitive determination of cfDNA concentrations. However, further investigations should consider longitudinal designs, standardized and controlled exercise settings, serial blood sampling, and large and homogeneous collectives. Additional exercise modalities should be investigated to establish whether the increase of cfDNA is due to eccentric muscle damage and whether cfDNA has utility across different exercise modalities with similar metabolic demands like cycling, or different metabolic demands such as resistance exercise. Besides related markers indicating the origin of exercise-induced cfDNA, its source needs to be proven directly by means of epigenetic pattern. Furthermore, it is important to define a standardized laboratory procedure for the measurement of cfDNA concentrations to ensure better comparability and transferability of the results from various investigations. With regard to cfDNA-related research in clinical issues, exercise settings like the incremental treadmill test should be considered as practicable models for studying the mechanisms of acute variations of cfDNA concentrations in patients and healthy persons (7, 8, 24) .
